AstraZeneca Weighs Options for Astra Tech Device Unit

Lock
This article is for subscribers only.

AstraZeneca Plc said it’s reviewing “strategic options” for Astra Tech, a Swedish unit that makes dental implants and medical devices, and has hired JPMorgan Chase & Co. as an adviser.

The drugmaker is seeking about $2 billion for the unit, people with knowledge of the matter said earlier this week. JPMorgan contacted prospective buyers in recent days and plans to approach other medical-device makers and private-equity firms, said the people, who declined to be identified because the matter is private.